"Онкологи "ЕвроСитиКлиник" проводят лекарственное лечение онкологических заболеваний в соответствии с международными клиническими рекомендациями и стандартами качества. Используются оригинальные таргетные и иммунопрепараты. Проводится лечение по полису ОМС. Консультаруют врачи различных специальностей, выполняются анализы, УЗИ, ЭКГ, ИГХ, молекулярно-генетические исследования."

During the past decade, LLC "EuroCityClinic" conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "LLC "EuroCityClinic"" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Janssen Research & Development, LLC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored, "Takeda" with 1 trials sponsored and "Yuhan Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "LLC "EuroCityClinic"" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "LLC "EuroCityClinic"" are "Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Clear Cell Renal Cell Carcinoma" (1 trials), "Metastatic Non-small Cell Lung Cancer" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "LLC "EuroCityClinic"" in a lesser frequency.

Most popular intervention types in "LLC "EuroCityClinic"" are "Drug" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Pemetrexed" (3 trials), "Cisplatin" (2 trials), "Nivolumab" (2 trials) and "5-FU" (1 trials). Other intervention names were less common.

The vast majority of trials in "LLC "EuroCityClinic"" are 6 trials for "All" genders.

Currently, there are NaN active trials in "LLC "EuroCityClinic"". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in LLC "EuroCityClinic", undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in LLC "EuroCityClinic", 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".